Total and utter nonsense. The plaintiff would not have a cause of action. Any such lawsuit would be thrown out at the motion to dismiss stage (very early) and if I was representing NWBO I would file a motion for fees and costs (motion for sanctions) b/c any 1st yr law student should know that such a claim is not supported by existing law.
You are confusing and confounding result publication with market approval and manufacturing readiness. Just because you don’t know results, does not mean the process of finally getting this to patients (commercially) is delayed due to your current transitory state of result ignorance.
Not surprisingly LC2020, this is a nonsensical reply.
You are saying that someone would have grounds to sue for harm done related to an investigational product that they have not taken and not only is it not marketed in the US, but not marketed anywhere in the world. One that not only does not have an anticipated release date, but to the best of the public’s knowledge has not even submitted a licensing application anywhere in the world. A product that you claim has no efficacy data or expectation for approval in the near to mid-term at all. A product that some here suggest has already failed its trial, information which is being withheld in order to swindle investors into not only holding stock in a failed enterprise but also exercising warrants with new investment dollars in that enterprise.
If you sincerely believe that you would have a valid reason to sue NWBO for this, then you are admitting that all of the theories that cast doubt on DCVaX-L have no basis in truth.